Global Interventional Cardiovascular Devices Market to register 8.36% CAGR through 2024

October 30, 2019


According to the new research report available at MarketStudyReport.com under the title ‘Global Interventional Cardiovascular Devices Market: Analysis By Product Type (Catheter, Stent, Balloon, Guidewire, Systems), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, Germany, U.K, Japan, China, India, Brazil)’, the worldwide interventional cardiovascular devices market is expected to surpass 8.36% CAGR by the year 2024.
 

The market is driven on account of several factors such as growing awareness for minimally invasive cardiac processes, prevailing unhealthy lifestyle habits, and growing elderly population.
 

Increasing medical developments with a surge in the number of medical facilities is anticipated to boost interventional cardiovascular devices market demand. However, strict approval procedures for peripheral vascular devices, interventional cardiology and high treatment cost of devices such as drug eluting balloons and stents are likely to hinder the market growth.
 

According to the research, interventional cardiovascular devices market is anticipated to grow with a CAGR of 8.36% through 2024. The research also provides an in-depth understanding about revenue share and growth patterns for each segment and manufacturer, alongside the trends, drivers, and challenges impacting the market growth.
 

Interventional cardiovascular devices market is examined on the basis of product type and regional landscape. Speaking of the product type, the market is segmented as balloon, stent, systems, catheter, and guidewire. Among these, the stent segment emerged dominant in the market and is anticipated to retain its dominance throughout the forecast time frame.

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2132825/
 

Considering the regional landscape, the market is divided into four main regions which are North America, Asia Pacific, Europe, and rest of the world. North America dominated the market with the largest share in the year 2018. However, it has been claimed that APAC interventional cardiovascular devices market size is likely to depict the highest CAGR through 2024.
 

The prominent companies operating in interventional cardiovascular devices market include Terumo Corporation, Abbott Laboratories, Medtronic, Acrostak, Johnson & Johnson, B. Braun, Edwards Lifesciences Corporation, Melsungen, Cardinal Health, Biosensors International, and Boston Scientific Corporation.


Frequently Asked Questions (FAQ) :

The market is driven on account of several factors such as growing awareness for minimally invasive cardiac processes, prevailing unhealthy lifestyle habits, and growing aged population.
North America dominated the market with the largest share in the year 2018.
APAC interventional cardiovascular devices market size is likely to depict the highest CAGR through 2024.
Terumo Corporation, Abbott Laboratories, Medtronic, Acrostak, Johnson & Johnson, B. Braun, Edwards Lifesciences Corporation, Melsungen, Cardinal Health, Biosensors International, and Boston Scientific Corporation.